Department of Pharmacology and Therapeutic, State University of Maringá (UEM), Avenue Colombo, 5790, Maringa, PR, 87020-900, Brazil.
Post-Graduation Program of Food Technology (PPGTA), Federal University of Technology - Paraná (UTFPR), P O Box 271, BR 369, km 0.5, Campo Mourão, PR, 87301-006, Brazil.
Inflammation. 2021 Apr;44(2):604-616. doi: 10.1007/s10753-020-01360-4. Epub 2020 Nov 9.
The present study evaluated the anti-inflammatory effect of nanoencapsulated curcuminoid preparations of poly(vinyl pyrrolidone) (Nano-cur) and free curcuminoids (Cur) in an experimental model of croton oil-induced cutaneous inflammation. Male Swiss mice, weighing 25-30 g, received oral treatment by gavage 1 h before CO application or topical treatment immediately after CO application (200 μg diluted in 70% acetone) with a single dose of Cur and Nano-cur. After 6 h, the animals were anesthetized and euthanized. The ears were sectioned into disks (6.0 mm diameter) and used to determine edema, myeloperoxidase (MPO) activity, and oxidative stress. Photoacoustic spectroscopy (PAS) was used to evaluate the percutaneous penetration of Cur and Nano-cur. Topical treatment with both preparations had a similar inhibitory effect on the development of edema, MPO activity, and the oxidative response. The PAS technique showed that the percutaneous permeation of both topically applied preparations was similar. Oral Nano-cur administration exerted a higher anti-inflammatory effect than Cur. Topical Cur and Nano-cur application at the same dose similarly inhibited the inflammatory and oxidative responses. Oral Nano-cur administration inhibited such responses at doses that were eight times lower than Cur, suggesting the better bioavailability of Nano-cur compared with Cur.Graphical abstract.
本研究评价了聚(吡咯烷酮)纳米包裹姜黄素制剂(Nano-cur)和游离姜黄素(Cur)在巴豆油诱导的皮肤炎症实验模型中的抗炎作用。雄性瑞士小鼠,体重 25-30g,在 CO 应用前 1h 通过灌胃给予单次剂量的 Cur 和 Nano-cur 进行口服治疗,或在 CO 应用后(用 70%丙酮稀释至 200μg)进行局部治疗。6h 后,对动物进行麻醉并安乐死。将耳朵切成圆盘(直径 6.0mm),用于测定水肿、髓过氧化物酶(MPO)活性和氧化应激。光声光谱(PAS)用于评估 Cur 和 Nano-cur 的经皮渗透。两种制剂的局部治疗对水肿、MPO 活性和氧化反应的发展均具有相似的抑制作用。PAS 技术表明,两种局部应用制剂的经皮渗透相似。口服 Nano-cur 给药比 Cur 具有更高的抗炎作用。相同剂量的局部应用 Cur 和 Nano-cur 同样抑制炎症和氧化反应。口服 Nano-cur 给药在比 Cur 低 8 倍的剂量下抑制这些反应,表明 Nano-cur 与 Cur 相比具有更好的生物利用度。